Non-invasive, pain free
Diabetes Screening & Monitoring
Diabetes is a growing global problem that affects the daily lives of millions of people and the future lives of many millions more.
We’re pioneering optical diagnostic technologies, to deliver painless, contact-free screening & monitoring of diabetes.
The Diabetes Problem
We're pioneering technological solutions to screen for, and monitor, some of humanity's greatest health challenges. Starting with diabetes.
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates the amount of sugar within the blood. It is incredibly important that sugar levels in the blood are kept within certain levels for the body to function effectively. If sugar levels are too low or too high, over time this can lead to serious damage to many of the body's systems, especially the nerves and blood vessels.
A growing problem...
The scale of diabetes is such that it is now being described as a pandemic and in the UK alone there are 4.7 million people suffering from the condition. But that headline ignores one aspect of the problem that isn't getting the attention it deserves. Of that 4.7 million there are 900,000 people with diabetes that haven't been diagnosed and a further third of all adults - almost 17 million people - who have pre-diabetes and are very likely to go on to develop full diabetes within 10 years. But diabetes isn't just a UK problem - it's a global one!
Diabetes Facts & Stats - A Global Problem
Globally, an estimated 240 million people are living with undiagnosed diabetes
Diabetes is responsible for 6.7 million deaths in 2021 - 1 every 5 seconds.
In 2021 approximately 537 million adults were living with diabetes
By 2045 it is estimated that 783 million people will be living with diabetes
Direct health expenditures due to diabetes are already close to one $1 trillion.
More than 1.1 million children and adolescents are living with type 1 diabetes
The signs of Type 2 diabetes are often not obvious, that’s why spotting them early can be life-changing. Early diagnosis means that fewer people will experience diabetes-related complications such as sight loss, amputation, kidney failure, stroke and heart disease because they could seek support to manage their condition effectively as soon as possible.
Chris Askew, Chief Executive of Diabetes UK
Occuity Diabetes Screening
With the scale of diabetes a growing problem, early intervention is crucial as the longer diabetes goes undetected, the more damaging its effects can be. However for diabetes to be detected effectively, a viable, simple to use device that can be used repeatedly in a non-clinical setting is required – namely the Occuity Diabetes Screening device.
The need for early detection and Diabetes screening
We are working on the development of a diabetes screening device that will be capable of being used by both clinicians and non-clinicians. It will be available as a service in opticians, pharmacies and care homes or even for personal use by individuals themselves in entirely non-clinical settings.
Occuity Diabetes Monitoring
Instead of relying on finger-prick blood tests to provide blood glucose readings, Occuity is in the process of developing a non-contact, handheld, optical meter to determine the blood glucose level by measuring subtle changes within the anterior chamber of the eye.
There are numerous medical papers that support the direct correlation of changes within the anterior chamber with fluctuations in blood glucose. The glucose monitor under development by Occuity builds on this correlation.
Join Our Community
If you're affected by diabetes or know someone who is, we would love your support and help. Occuity has a mission to improve the screening and monitoring of some of humanity's greatest health challenges - starting with diabetes.
If you believe in our vision, please sign up as only if we have your support are we ever going to be successful in creating a better way to screen and monitor for this disease.